Yang Luke Chen Sells 49,920 Shares of 111 (NASDAQ:YI) Stock

111, Inc. Sponsored ADR (NASDAQ:YI) Director Yang Luke Chen sold 49,920 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $0.23, for a total value of $11,481.60. Following the transaction, the director owned 539,462 shares in the company, valued at $124,076.26. This trade represents a 8.47% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Yang Luke Chen also recently made the following trade(s):

• On Monday, June 15th, Yang Luke Chen sold 44,000 shares of 111 stock. The stock was sold at an average price of $0.23, for a total value of $10,120.00.
• On Wednesday, May 27th, Yang Luke Chen sold 3,400 shares of 111 stock. The stock was sold at an average price of $0.25, for a total value of $850.00.
• On Tuesday, May 26th, Yang Luke Chen sold 1,440 shares of 111 stock. The stock was sold at an average price of $0.27, for a total value of $388.80.

111 Stock Performance

YI stock opened at $4.41 on Thursday. 111, Inc. Sponsored ADR has a fifty-two week low of $2.48 and a fifty-two week high of $11.17. The business’s 50 day moving average price is $5.80 and its two-hundred day moving average price is $5.67. The company has a market capitalization of $38.76 million, a price-to-earnings ratio of -3.15 and a beta of 0.60.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings cut 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, June 4th. One analyst has rated the stock with a Sell rating, According to MarketBeat, 111 currently has a consensus rating of “Sell”.

111 Company Profile

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.